Posters featuring TILT technology presented at the 11th International Oncolytic Virus Conference in Oxford in Oxford, UK, in April 2018.
Facilitating T-cell therapy in solid tumors with oncolytic adenovirus
Enhancing dendritic cell therapy with oncolytic adenovirus 3 coding for CD40L